[1]
“Efficacy and Cost of Molecular Identification of Clinical Mycobacterial Isolates in a Resource Limited Setting”, SAARC J. Tuber. Lung Dis. HIV/AIDS, vol. 13, no. 1, pp. 23–31, Mar. 2017, doi: 10.3126/saarctb.v13i1.16925.